sanofi-aventis homepage

New to LANTUS®

Whether you've switched to LANTUS® after using another insulin, or LANTUS® is the first insulin you've ever used, this section can help you get the most from LANTUS®, the only 24-hour insulin approved exclusively for use once a day.

LANTUS® is a long-acting insulin that is taken once a day, any time of the day, at the same time each day. It works steadily and consistently to help manage blood sugar control around the clock. LANTUS® is usually taken in combination with oral diabetes medications.

Many people, just like you, successfully use LANTUS® insulin for blood sugar control. While there's no secret to their success, there is one common factor many of them share: they know what it takes to achieve results.

  1. Dosing is very important. And sometimes it may need to be adjusted.
    Your healthcare professional may start you on a low initial dose, which may then be adjusted to reach the dose that's best for you. This is a normal part of treatment for diabetes.

  2. LANTUS® is not a "stand-alone" diabetes therapy.
    LANTUS® insulin works in combination with other diabetes medicines and routines, including a healthy diet and regular exercise.

  3. Proper treatment takes time.
    Finding just the right dose and the right balance of insulin, diet, exercise and other diabetes medications for you is an ongoing process, not a one-time fix.

So, give LANTUS® time. And check in regularly with your healthcare professional so he or she knows exactly how your treatment is going.

Important Safety Information for Lantus®

Do not take Lantus® if you are allergic to insulin or any of the inactive ingredients in Lantus®.

You must test your blood sugar levels while using insulin, such as Lantus®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Lantus® with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus® must only be used if the solution is clear and colorless with no particles visible. Do not share needles, insulin pens or syringes with others.

The most common side effect of insulin, including Lantus®, is low blood sugar (hypoglycemia), which may be serious. Other possible side effects may include injection site reactions, including changes in fat tissue at the injection site, and allergic reactions, including itching and rash. In rare cases, some allergic reactions may be life threatening.

Tell your doctor about other medicines and supplements you are taking because they can change the way insulin works. Before starting Lantus®, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or planning to breast-feed.

Indications and Usage

Prescription Lantus® is a long-acting insulin used to treat adults with type 2 diabetes and adults and children (6 years and older) with type 1 diabetes for the control of high blood sugar. It should be taken once a day at the same time each day to lower blood glucose.

Do not use Lantus® to treat diabetic ketoacidosis.

Lantus® SoloSTAR® is a disposable prefilled insulin pen.

OptiClik® is a reusable insulin delivery device for use with a 3-mL Lantus® cartridge (U-100).

Click here for additional important information for Lantus®.

Click here for information on drug anti-counterfeiting.

The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.
Footer
Prescription Lantus® is available in pharmacies.
© 2002-2010 sanofi-aventis U.S. LLC. All rights reserved.
Legal Disclaimer Information and Privacy Policy
Questions or Comments? Click here to contact us.
This site intended for use by US residents only.
US.GLA.08.11.024       Last Update: November 2008